Search Results

There are 539795 results for: content related to: Which patients benefit from hemodialysis therapy in hepatorenal syndrome?

  1. Use of an In Vitro Model of Renal Replacement Therapy Systems to Estimate Extracorporeal Drug Removal

    The Journal of Clinical Pharmacology

    Volume 52, Issue S1, January 2012, Pages: 35S–44S, Mariann D. Churchwell

    Article first published online : 23 APR 2013, DOI: 10.1177/0091270011415979

  2. Detectability of Vasopressin in Continuous Venovenous Hemodialysis Effluent of Patients with Vasodilatory Shock Treated with Exogenous Arginine Vasopressin

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 31, Issue 9, September 2011, Pages: 857–862, Dr. Seth R. Bauer, Dr. Daniel A. Culver, Ms. Susamma Abraham, Dr. Simon W. Lam, Dr. William H. Fissell, Dr. Herbert P. Wiedemann and Dr. Anita J. Reddy

    Article first published online : 6 JAN 2012, DOI: 10.1592/phco.31.9.857

  3. Effect of hemodiafiltration and sepsis on chemotaxis of granulocytes and the release of IL-8 and IL-10

    Acta Anaesthesiologica Scandinavica

    Volume 46, Issue 2, February 2002, Pages: 138–144, P. Toft, V. Brix-Christensen, J. Bæch, J. Krog, H. S. Jørgensen, E. Tønnesen, T. K. Petersen and F. Dagnæs-Hansen

    Article first published online : 27 MAR 2002, DOI: 10.1034/j.1399-6576.2002.460203.x

  4. Clearance of myoglobin by high cutoff continuous veno-venous hemodialysis in a patient with rhabdomyolysis: A case report

    Hemodialysis International

    Buyun Wu, Dehua Gong, Daxi Ji, Bin Xu and Zhihong Liu

    Article first published online : 27 APR 2014, DOI: 10.1111/hdi.12172

  5. Influence of continuous venovenous haemodiafiltration on the pharmacokinetics of tacrolimus in liver transplant recipients with small-for-size grafts

    Clinical Transplantation

    Volume 17, Issue 5, October 2003, Pages: 412–416, S Kishino, Y Takekuma, M Sugawara, T Shimamura, H Furukawa, S Todo and K Miyazaki

    Article first published online : 17 SEP 2003, DOI: 10.1034/j.1399-0012.2003.00048.x

  6. Pharmacokinetics of Oseltamivir and Oseltamivir Carboxylate in Critically Ill Patients Receiving Continuous Venovenous Hemodialysis and/or Extracorporeal Membrane Oxygenation

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 32, Issue 12, December 2012, Pages: 1061–1069, Rachel F. Eyler, Michael Heung, Melissa Pleva, Kevin M. Sowinski, Pauline K. Park, Lena M. Napolitano and Bruce A. Mueller

    Article first published online : 3 DEC 2012, DOI: 10.1002/phar.1151

  7. Determinants of Ceftriaxone Clearance by Continuous Venovenous Hemofiltration and Hemodialysis

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 20, Issue 6, June 2000, Pages: 635–643, Dr. Gary R. Matzke, Dr. Reginald F. Frye, Dr. Melanie S. Joy and Dr. Paul M. Palevsky

    Article first published online : 17 JAN 2012, DOI: 10.1592/phco.20.7.635.35170

  8. Quality of pharmacokinetic studies in critically ill patients receiving continuous renal replacement therapy

    Acta Anaesthesiologica Scandinavica

    Volume 56, Issue 2, Febuary 2012, Pages: 147–157, S. VAARA, V. PETTILA and K.-M. KAUKONEN

    Article first published online : 19 OCT 2011, DOI: 10.1111/j.1399-6576.2011.02571.x

  9. Anticoagulation, delivered dose and outcomes in CRRT: The program to improve care in acute renal disease (PICARD)

    Hemodialysis International

    Volume 18, Issue 3, July 2014, Pages: 641–649, Rolando Claure-Del Granado, Etienne Macedo, Sharon Soroko, YeonWon Kim, Glenn M. Chertow, Jonathan Himmelfarb, T. Alp Ikizler, Emil P. Paganini and Ravindra L. Mehta

    Article first published online : 12 MAR 2014, DOI: 10.1111/hdi.12157

  10. Pharmakokinetik und Dosierung von Fluconazol bei kontinuierlichen Hämofiltrations- (CAVH, CVVH) und Hämodialyseverfahren (CAVHD, CVVHD)

    Mycoses

    Volume 41, Issue s2, October 1998, Pages: 86–88, L. Pittrow and A. Penk

    Article first published online : 24 APR 2009, DOI: 10.1111/j.1439-0507.1998.tb00610.x

  11. A Pilot Study of Netilmicin Pharmacokinetics During Continuous Venovenous Hemodiafiltration

    The Journal of Clinical Pharmacology

    Volume 45, Issue 4, April 2005, Pages: 477–481, Ms Maria Syka, Dr Sophia L. Markantonis, Dr Christos Mathas and Dr Nina Maggina

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270004273949

  12. Severe carbamazepine intoxication unresponsive to albumin-enhanced continuous venovenous hemodiafiltration with low dialysate flow

    Hemodialysis International

    Volume 18, Issue 2, April 2014, Pages: 551–555, Young K. Chung, Kyung Y. Chang, Hoon S. Park, Mi-Hee Kim, Kang-Min Lee, Tae-Seok Lim and Hyung W. Kim

    Article first published online : 15 JAN 2014, DOI: 10.1111/hdi.12132

  13. You have free access to this content
    Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration

    British Journal of Clinical Pharmacology

    Volume 58, Issue 3, September 2004, Pages: 259–268, Megan E. DelDot, Jeffrey Lipman and Susan E. Tett

    Article first published online : 4 JUN 2004, DOI: 10.1111/j.1365-2125.2004.02143.x

  14. Treatment of Methotrexate Intoxication with Various Modalities of Continuous Extracorporeal Therapy and Glucarpidase

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 30, Issue 1, January 2010, Page: 111, A. Mary Vilay, Bruce A. Mueller, Hilary Haines, Jeffery A. Alten and David J. Askenazi

    Article first published online : 6 JAN 2012, DOI: 10.1592/phco.30.1.111

  15. Meropenem and Continuous Renal Replacement Therapy: In Vitro Permeability of 2 Continuous Renal Replacement Therapy Membranes and Influence of Patient Renal Function on the Pharmacokinetics in Critically Ill Patients

    The Journal of Clinical Pharmacology

    Volume 45, Issue 11, November 2005, Pages: 1294–1304, Ms Arantxazu Isla, Dr Javier Maynar, Dr José Ángel Sánchez-Izquierdo, Dr Alicia R. Gascón, Ms Alazne Arzuaga, Dr Esther Corral and Dr José Luis Pedraz

    Article first published online : 8 MAR 2013, DOI: 10.1177/0091270005280583

  16. Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy in the Perioperative Care of Liver Transplant Recipients: A Single Center Experience

    Therapeutic Apheresis and Dialysis

    Christoph Sponholz, Utz Settmacher, Michael Bauer and Andreas Kortgen

    Article first published online : 4 SEP 2014, DOI: 10.1111/1744-9987.12196

  17. Dosage adjustment of fluconazole during continuous renal replacement therapy (CAVH, CVVH, CAVHD, CVVHD)

    Mycoses

    Volume 42, Issue 1-2, January 1999, Pages: 17–19, L. Pittrow and A. Penk

    Article first published online : 1 MAR 2002, DOI: 10.1046/j.1439-0507.1999.00269.x

  18. Amino Acid Requirements in Critically Ill Patients with Acute Kidney Injury Treated with Continuous Renal Replacement Therapy

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 28, Issue 5, May 2008, Pages: 600–613, Dr. Imad F. Btaiche, Dr. Rima A. Mohammad, Dr. Cesar Alaniz and Dr. Bruce A. Mueller

    Article first published online : 6 JAN 2012, DOI: 10.1592/phco.28.5.600

  19. Drug Dosing in Critically Ill Patients with Renal Failure: A Pharmacokinetic Approach

    Journal of Intensive Care Medicine

    Volume 15, Issue 6, November/December 2000, Pages: 273–313, Ronald J DeBellis, Brian S Smith, Pauline A Cawley and Gail M Burniske

    Article first published online : 28 JUN 2008, DOI: 10.1046/j.1525-1489.2000.00273.x

  20. You have free access to this content
    In vitro comparison of the molecular adsorbent recirculation system (MARS) and single-pass albumin dialysis (SPAD)

    Hepatology

    Volume 39, Issue 5, May 2004, Pages: 1408–1414, Igor M. Sauer, Max Goetz, Ingo Steffen, Gesa Walter, Daniel C. Kehr, Ruth Schwartlander, Yoon J. Hwang, Andreas Pascher, Joerg C. Gerlach and Peter Neuhaus

    Article first published online : 26 APR 2004, DOI: 10.1002/hep.20195